Atlas Trials

Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

Clinical trial NCT03030105 · COMPLETED

Trial details

NCT number
NCT03030105
Sponsor
Tetra Discovery Partners
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2017-01-01
Primary completion
2017-05-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.